BAK vs LIN
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
BAK exhibits severe financial distress, as evidenced by a Piotroski F-Score of 1/9, indicating extreme weakness in operational and financial health. The absence of an Altman Z-Score and the company's negative profitability metrics—such as a -7.11% profit margin, -9.65% operating margin, and -2.76% ROA—underscore deteriorating fundamentals. Despite a recent 14.9% 1-year return, the stock has declined 61.9% over five years, reflecting persistent underperformance. The negative forward P/E of -2.25 and Price/Book of -5.01 signal deep value traps, while the lack of dividend and weak insider sentiment further erode confidence. Analysts maintain a 'hold' recommendation, reflecting cautious optimism amid structural challenges.
LIN shows neutral fundamentals based on deterministic rules. Financial strength is stable (F-Score 4/9). Mixed signals with both opportunities and risks present.
Compare Another Pair
Related Comparisons
BAK vs LIN: Head-to-Head Comparison
This page compares Braskem S.A. (BAK) and Linde plc (LIN) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.